Tenders of Dak Gesundheit

Tenders of Dak Gesundheit

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient formoterol, beclometasone, glycopyrronium, Atc R03al09 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient allergen extract from birch pollen, Atc V01aa05 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient Follitropin Beta, Atc G03ga06 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 SGB V for the active ingredient Enoxaparin (only individual potency-standard size combinations), Atc B01ab05 for the period November 1st, 2023 - October 31st, 2025
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 Sgb V for the active substance teriflunomide, Atc L04aa31 for the period 10/01/2023 - 09/30/2025 (1004033 - teriflunomide, Atc L04aa31)
Closing Date5 Aug 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Chemical Products
Germany
Conclusion of a non-exclusive discount agreement according to § 130a Para. 8 Sgb V for the active ingredient iron-ii-sulphate, Atc B03aa07 for the period October 1st, 2023 - September 30th, 2025 (1004033 - iron-ii-sulphate, Atc B03aa07)
Closing Date5 Aug 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Healthcare and Medicine
Germany
Conclusion of a non-exclusive discount agreement according to § 130a paragraph 8 Sgb V for the active substance filgotinib, Atc L04aa45 for the period 15.10.2023 - 31.10.2025 (1004034 - filgotinib, Atc L04aa45)
Closing Date5 Sep 2025
Tender AmountRefer Documents 

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Aug 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Aug 2025
Tender AmountEUR 1 (USD 1)

DAK Gesundheit Tender

Germany
Germany-hamburg: Pharmaceutical Products
Closing Date5 Sep 2025
Tender AmountEUR 1 (USD 1)
231-240 of 329 active Tenders